{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T17:14:32Z","timestamp":1791566072855,"version":"4.3.4"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2020,1,7]],"date-time":"2020-01-07T00:00:00Z","timestamp":1578355200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,1,7]],"date-time":"2020-01-07T00:00:00Z","timestamp":1578355200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1007\/s00415-019-09686-2","type":"journal-article","created":{"date-parts":[[2020,1,7]],"date-time":"2020-01-07T10:02:31Z","timestamp":1578391351000},"page":"1137-1146","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":87,"title":["Systematic review of the clinical spectrum of CASPR2 antibody syndrome"],"prefix":"10.1007","volume":"267","author":[{"given":"Matthew","family":"Boyko","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ka Loong Kelvin","family":"Au","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colin","family":"Casault","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula","family":"de Robles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7657-7098","authenticated-orcid":false,"given":"Gerald","family":"Pfeffer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,1,7]]},"reference":[{"key":"9686_CR1","doi-asserted-by":"publisher","first-page":"1906","DOI":"10.1111\/ejn.14081","volume":"48","author":"M Saint-Martin","year":"2018","unstructured":"Saint-Martin M, Joubert B, Pellier-Monnin V, Pascual O, Noraz N, Honnorat J (2018) Contactin-associated protein-like 2, a protein of the neurexin family involved in several human diseases. Eur J Neurosci 48:1906\u20131923","journal-title":"Eur J Neurosci"},{"issue":"8","key":"9686_CR2","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1016\/S1474-4422(10)70137-X","volume":"9","author":"M Lai","year":"2010","unstructured":"Lai M, Huijbers MG, Lancaster E, Graus F, Bataller L, Balice-Gordon R, Cowell JK, Dalmau J (2010) Investigation of LGI1 as the antigen in limbic encephalitis previously attributed to potassium channels: a case series. Lancet Neurol 9(8):776\u2013785","journal-title":"Lancet Neurol"},{"issue":"9","key":"9686_CR3","doi-asserted-by":"publisher","first-page":"2734","DOI":"10.1093\/brain\/awq213","volume":"133","author":"SR Irani","year":"2010","unstructured":"Irani SR, Alexander S, Waters P et al (2010) Antibodies to Kv1 potassium channel-complex proteins leucine-rich, glioma inactivated 1 protein and contactin-associated protein-2 in limbic encephalitis, Morvan\u2019s syndrome and acquired neuromyotonia. Brain 133(9):2734\u20132748","journal-title":"Brain"},{"issue":"1","key":"9686_CR4","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1111\/ene.13180","volume":"24","author":"CG Bien","year":"2017","unstructured":"Bien CG, Mirzadjanova Z, Baumgartner C, Onugoren MD, Grunwald T, Holtkamp M, Isenmann S, Kermer P, Melzer N, Naumann M, Riepe M, Schabitz WR, von Oertzen TJ, von Podewils F, Rauschka H, May TW (2017) contactin-associated protein-2 encephalitis: relevance of antibody titres, presentation, and outcome. Eur J Neurol 24(1):175\u2013186","journal-title":"Eur J Neurol"},{"issue":"1","key":"9686_CR5","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1002\/ana.24979","volume":"82","author":"A Gadoth","year":"2017","unstructured":"Gadoth A, Pittock SJ, Dubey D, McKeon A, Britton JW, Schmeling JE, Smith A, Kotsenas AL, Watson RE, Lachance DH, Flanagan EP, Lennon VA, Klein CJ (2017) Expanded phenotypes and outcomes among 256 LGI1\/CASPR2-IgG-positive patients. Ann Neurol 82(1):79\u201392","journal-title":"Ann Neurol"},{"key":"9686_CR6","doi-asserted-by":"crossref","unstructured":"van Sonderen A, Ari\u00f1o H, Petit-Pedrol M, Leypoldt F, K\u00f6rtv\u00e9lyessy P, Wandinger KP, Lancaster 1, Wirtz PW, Schreurs MW, Sillevis Smitt PA, Graus F, Dalmau J, Titulaer MJ. The clinical spectrum of Caspr2 antibody-associated disease. Neurology. (2016); 87(5): 521\u20138.","DOI":"10.1212\/WNL.0000000000002917"},{"issue":"4","key":"9686_CR7","doi-asserted-by":"publisher","first-page":"e371","DOI":"10.1212\/NXI.0000000000000371","volume":"4","author":"B Joubert","year":"2017","unstructured":"Joubert B, Gobert F, Thomas L, Saint-Martin M, Desestret V, Convers P, Rogemond V, Picard G, Ducray F, Psimaras D, Antoine JC, Delattre JY, Honnorat J (2017) Autoimmune episodic ataxia in patients with CASPR2 antibody-associated encephalitis. Neurol Neuroimmunol Neuroinflamm 4(4):e371","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"1","key":"9686_CR8","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1002\/ana.24189","volume":"76","author":"L Dahm","year":"2014","unstructured":"Dahm L, Ott C, Steiner J, Stepniak B, Teegen B, Saschenbrecker S, Hammer C, Borowski K, Begemann M, Lemke S, Rentzsch K, Probst C, Martens H, Wienands J, Spalletta G, Weissenborn K, St\u00f6cker W, Ehrenreich H (2014) Seroprevalence of autoantibodies against brain antigens in health and disease. Ann Neurol 76(1):82\u201394","journal-title":"Ann Neurol"},{"issue":"2","key":"9686_CR9","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1001\/jamaneurol.2013.592","volume":"70","author":"CJ Klein","year":"2013","unstructured":"Klein CJ, Lennon VA, Aston PA, McKeon A, O'Toole O, Quek A, Pittock SJ (2013) Insights from LGI1 and CASPR2 potassium channel complex autoantibody subtyping. JAMA Neurol 70(2):229\u2013234","journal-title":"JAMA Neurol"},{"issue":"11","key":"9686_CR10","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1212\/WNL.0b013e3182698cab","volume":"79","author":"CJ Klein","year":"2012","unstructured":"Klein CJ, Lennon VA, Aston PA, McKeon A, Pittock SJ (2012) Chronic pain as a manifestation of potassium channel-complex autoimmunity. Neurology 79(11):1136\u20131144","journal-title":"Neurology"},{"issue":"8","key":"9686_CR11","doi-asserted-by":"publisher","first-page":"2263","DOI":"10.1093\/brain\/awy109","volume":"141","author":"S Binks","year":"2018","unstructured":"Binks S, Varley J, Lee W, Makuch M, Elliott K, Gelfand JM, Jacob S, Leite MI, Maddison P, Chen M, Geschwind MD, Grant E, Sen A, Waters P, McCormack M, Cavalleri GL, Barnardo M, Knight JC, Irani SR (2018) Distinct HLA associations of LGI1 and CASPR2-antibody diseases. Brain 141(8):2263\u20132271","journal-title":"Brain"},{"key":"9686_CR12","doi-asserted-by":"crossref","unstructured":"Moher D, Liberati A, Tetzlaff J, et al. Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement. PLoS Med. 2009;6(7).","DOI":"10.1371\/journal.pmed.1000097"},{"issue":"7","key":"9686_CR13","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1001\/jamaneurol.2016.0603","volume":"73","author":"A Zekeridou","year":"2016","unstructured":"Zekeridou A, McKeon A, Lennon VA (2016) Frequency of synaptic autoantibody accompaniments and neurological manifestations of thymoma. JAMA Neurol. 73(7):853\u2013859","journal-title":"JAMA Neurol."},{"issue":"1","key":"9686_CR14","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1097\/NRL.0000000000000097","volume":"22","author":"M Nagappa","year":"2017","unstructured":"Nagappa M, Mahadevan A, Sinha S et al (2017) Fatal Morvan syndrome associated with myasthenia gravis. Neurologist. 22(1):29\u201333","journal-title":"Neurologist."},{"key":"9686_CR15","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.jocn.2017.02.063","volume":"41","author":"J Song","year":"2017","unstructured":"Song J, Jing S, Quan C et al (2017) Isaacs syndrome with CASPR2 antibody: A series of three cases. J Clin Neurosci. 41:63\u201366","journal-title":"J Clin Neurosci."},{"issue":"4","key":"9686_CR16","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1016\/j.neuron.2018.01.033","volume":"97","author":"JM Dawes","year":"2018","unstructured":"Dawes JM, Weir GA, Middleton SJ et al (2018) Immune or Genetic-Mediated Disruption of CASPR2 Causes Pain Hypersensitivity Due to Enhanced Primary Afferent Excitability. Neuron 97(4):806\u2013822.e10","journal-title":"Neuron"},{"issue":"1\u20132","key":"9686_CR17","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.jns.2013.01.040","volume":"327","author":"B Balint","year":"2013","unstructured":"Balint B, Regula JU, Jarius S, Wildemann B (2013) Caspr2 antibodies in limbic encephalitis with cerebellar ataxia, dyskinesias and myoclonus. J Neurol Sci. 327(1\u20132):73\u201374","journal-title":"J Neurol Sci."},{"issue":"1","key":"9686_CR18","first-page":"74","volume":"71","author":"A Salvador","year":"2013","unstructured":"Salvador A, Pujadas F, Dalmau J et al (2013) Determination of Neuronal Antibodies in Suspected and Definite Creutzfeldt-Jakob Disease. JAMA Neurol. 71(1):74","journal-title":"JAMA Neurol."},{"issue":"6","key":"9686_CR19","doi-asserted-by":"publisher","first-page":"e178","DOI":"10.1212\/NXI.0000000000000178","volume":"2","author":"P Maat","year":"2015","unstructured":"Maat P, Beukelaar JW, Jansen C et al (2015) Pathologically confirmed autoimmune encephalitis in suspected Creutzfeldt-Jakob disease. Neurol - Neuroimmunol Neuroinflammation. 2(6):e178","journal-title":"Neurol - Neuroimmunol Neuroinflammation."},{"issue":"1","key":"9686_CR20","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1186\/s12883-014-0227-7","volume":"14","author":"F Zuhorn","year":"2014","unstructured":"Zuhorn F, Hubenthal A, Rogalewski A et al (2014) Creutzfeldt-Jakob disease mimicking autoimmune encephalitis with CASPR2 antibodies. BMC Neurol. 14(1):227","journal-title":"BMC Neurol."},{"issue":"6","key":"9686_CR21","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1136\/jnnp-2014-308695","volume":"86","author":"M Rossi","year":"2015","unstructured":"Rossi M, Mead S, Collinge J, Rudge P, Vincent A (2015) Neuronal antibodies in patients with suspected or confirmed sporadic Creutzfeldt-Jakob disease. J Neurol Neurosurg Psychiatry. 86(6):692\u2013694","journal-title":"J Neurol Neurosurg Psychiatry."},{"issue":"96","key":"9686_CR22","first-page":"24","volume":"2019","author":"J Broadley","year":"2018","unstructured":"Broadley J, Seneviratne U, Beech P et al (2018) Prognosticating autoimmune encephalitis: A systematic review. J Autoimmun. 2019(96):24\u201334","journal-title":"J Autoimmun."},{"key":"9686_CR23","doi-asserted-by":"crossref","unstructured":"Vanli-Yavuz EN, Erdag E, Tuzun E, et al. Neuronal autoantibodies in mesial temporal lobe epilepsy with hippocampal sclerosis. J Neurol Neurosurg Psychiatry. 2016;87(7):684\u2013692.","DOI":"10.1136\/jnnp-2016-313146"},{"issue":"10 SUPPL. 4","key":"9686_CR24","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1097\/JTO.0b013e3181f23f04","volume":"5","author":"A Vincent","year":"2010","unstructured":"Vincent A, Irani SR (2010) Caspr2 antibodies in patients with thymomas. J Thorac Oncol. 5(10 SUPPL. 4):277\u2013280","journal-title":"J Thorac Oncol."},{"issue":"2","key":"9686_CR25","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1002\/ana.23577","volume":"72","author":"SR Irani","year":"2012","unstructured":"Irani SR, Pettingill P, Kleopa KA et al (2012) Morvan syndrome: Clinical and serological observations in 29 cases. Ann Neurol. 72(2):241\u2013255","journal-title":"Ann Neurol."},{"issue":"10","key":"9686_CR26","first-page":"1311","volume":"70","author":"J Fleisher","year":"2013","unstructured":"Fleisher J, Richie M, Price R et al (2013) Acquired Neuromyotonia Heralding Recurrent Thymoma in Myasthenia Gravis. JAMA Neurol. 70(10):1311\u20131314","journal-title":"JAMA Neurol."},{"issue":"7","key":"9686_CR27","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1016\/j.sleep.2015.03.017","volume":"16","author":"G Abgrall","year":"2015","unstructured":"Abgrall G, Demeret S, Rohaut B et al (2015) Status dissociatus and disturbed dreaming in a patient with Morvan syndrome plus myasthenia gravis. Sleep Med. 16(7):894\u2013896","journal-title":"Sleep Med."},{"key":"9686_CR28","doi-asserted-by":"crossref","unstructured":"Torres-vega E, Mancheno N, Cebrian-Silla A, et al. Netrin-1 receptor antibodies in thymoma-associated neuromyotonia with myasthenia gravis. 2017;88(13):1235\u20131242.","DOI":"10.1212\/WNL.0000000000003778"},{"issue":"14","key":"9686_CR29","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1212\/WNL.0000000000005265","volume":"90","author":"H Hines","year":"2018","unstructured":"Hines H, Murray NM, Ahmad S, Jaradeh S, Gold CA (2018) Video NeuroImages: Paraneoplastic spinal myoclonus associated with Caspr2 antibodies. Neurology. 90(14):660\u2013661","journal-title":"Neurology."},{"issue":"23","key":"9686_CR30","doi-asserted-by":"publisher","first-page":"2076","DOI":"10.1212\/WNL.0000000000002037","volume":"85","author":"C Laurencin","year":"2015","unstructured":"Laurencin C, Andre-Obadia N, Camdessanche JP, Maugiere F, Ong E, Vukusic S, Peter-Derex L, Meyronet D, Bouhour F, Vial C, Ducray F, Honnorat J, Petiot P (2015) Peripheral small fibre dysfunction and neuropathic pain in patients with Morvan syndrome. Neurology 85(23):2076\u20132078","journal-title":"Neurology"},{"issue":"2","key":"9686_CR31","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1053\/j.semtcvs.2016.04.002","volume":"28","author":"AJ Kaufman","year":"2016","unstructured":"Kaufman AJ, Palatt J, Sivak M et al (2016) Thymectomy for Myasthenia Gravis: Complete Stable Remission and Associated Prognostic Factors in Over 1000 Cases. Semin Thorac Cardiovasc Surg. 28(2):561\u2013568","journal-title":"Semin Thorac Cardiovasc Surg."},{"issue":"6","key":"9686_CR32","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1056\/NEJMoa1602489","volume":"375","author":"GI Wolfe","year":"2016","unstructured":"Wolfe GI, Kaminski HJ, Aban IB et al (2016) Randomized trial of thymectomy in myasthenia gravis. N Engl J Med. 375(6):511\u2013522","journal-title":"N Engl J Med."},{"issue":"6","key":"9686_CR33","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1097\/CCO.0000000000000222","volume":"27","author":"R H\u00f6ftberger","year":"2015","unstructured":"H\u00f6ftberger R, Rosenfeld MR, Dalmau J (2015) Update on neurological paraneoplastic syndromes. Curr Opin Oncol. 27(6):489\u2013495","journal-title":"Curr Opin Oncol."}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-019-09686-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00415-019-09686-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-019-09686-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,6]],"date-time":"2021-01-06T00:40:50Z","timestamp":1609893650000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00415-019-09686-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,7]]},"references-count":33,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,4]]}},"alternative-id":["9686"],"URL":"https:\/\/doi.org\/10.1007\/s00415-019-09686-2","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1,7]]},"assertion":[{"value":"15 October 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 December 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 December 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 January 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"All authors declare there are no competing interests with this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"Institutional research ethics board approval was not obtained for this study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The participant provided written informed consent for publication of this case report.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}